Latest news on Laboratorytalk categorised by supplier
Nanogen
Address:
10398 Pacific Center Ct San Diego
92121
USA
Telephone: (USA) +1 877 626 6436
http://www.nanogen.com
Our RSS feed for news from Nanogen
Request to receive our free email newsletter each week
Listing of all 12 news releases from Nanogen:
Nanogen wins CDC contract for avian flu diagnostic
Goal is to develop POC immunoassay that simultaneously detects influenza type A, type B, seasonal flu (H1N1 and H3N2) and avian flu (H5N1) in a simple to use assay format
News from Nanogen ( 6 December 2006)
Nanogen releases new real-time PCR reagents
MGB Alert real-time PCR reagents assist laboratories in developing tests that can detect sequences associated with varicella-zoster virus (VZV, also called Human Herpesvirus 3) and Bordetella bacteria
News from Nanogen (28 July 2006)
Pharmacogenetics product achieves CE mark for IVD
Jurilab, a privately-held Finnish biotechnology company, and Nanogen announce that the European CE Mark for IVD (in vitro diagnostic) use has been achieved for the Drugmet pharmacogenetic test
News from Nanogen ( 4 May 2006)
Detection of Epstein-Barr virus (EBV)
EBV, Epstein-Barr virus, is the causative agent of infectious mononucleosis and also underlies several other lymphoproliferative disorders such as Burkitt's lymphoma
News from Nanogen (27 April 2006)
Nanogen to buy diagnostics firm Amplimedical
Based in Italy, the Amplimedical diagnostics division has been active in the European and other markets since the early 1990s with its molecular diagnostic reagents
News from Nanogen (24 April 2006)
Expanding reach into molecular diagnostics
Nanogen, developer of advanced diagnostic products, announced that Fisher Scientific International has agreed to purchase approximately 5.7 million shares of Nanogen common stock at $2.65 per share
News from Nanogen (22 March 2006)
Acquisition of point-of-care cardiac diagnostics
Cardiac Status line includes four FDA-cleared tests that can be used at the point-of-care to determine elevations of cardiac markers, diagnose acute coronary syndrome (ACS) as indicated by chest pain
News from Nanogen ( 9 February 2006)
Detection of respiratory viral pathogens
Nanogen has expanded its molecular reagent product portfolio to include two new products to detect sequences for respiratory viral pathogens
News from Nanogen (14 December 2005)
Molecular biology on second-generation chip system
Open and robust platform allows laboratories to use one system for multiple molecular applications, including the detection of SNPs and multi-gene targets for pharmacogenetics
News from Nanogen (25 October 2005)
Fluorescent detection of nucleic acid targets
Technical background article Patent relates to latent fluorophore-minor groove binder oligonucleotide conjugates which fluoresce upon hybridisation to a target
News from Nanogen (13 October 2005)
Share sale to bolster balance sheet
"This financing will bolster our balance sheet as we prepare to launch products for the clinical, research and point-of-care markets," said Howard Birndorf, chairman and CEO
News from Nanogen (30 September 2005)
$2.5M to develop diagnostics for sepsis, pneumonia
User application article Grant will enable Nanogen to develop improved molecular biological methods, miniaturise those methods, and demonstrate this new molecular diagnostic approach in a hospital laboratory setting
News from Nanogen (15 August 2005)
